Billionaire Philanthropist Bill Gates said on Monday that India’s research and manufacturing work will be critical to fighting coronavirus, especially vaccine production on a large scale. Gates, while addressing the ‘Grand Challenges Annual Meeting 2020’, discussed the difficulties in the development of the COVID-19 vaccine.
India has been ‘very inspiring’: Gates
Gates said that India has been ‘very inspiring’ as it has made great progress in improving the health of its people in the last two decades. He said, “And now, India’s research and manufacturing will be critical to fighting Covid-19 especially when it comes to making vaccines at large scale.” Gates also stressed the need for innovation in identifying infections.
Researchers are breaking the system: Bill Gates
He said that researchers are breaking the system and instead of waiting to go through the publication process, they are sharing data on a daily basis. The Microsoft co-founder said, “Ever since the pandemic began, scientists have shared 1,37,000 viral covid-19 genomic sequences. Even pharmaceutical companies are collaborating on production methods that have never really been seen before. ‘
Probably, the first approved vaccine for COVID-19 will be mRNA: Gates
Talking about the challenges in vaccine development, he said that the mRNA vaccine is an area where many people have seen many promises. He said, ‘Probably, the first approved vaccine for COVID-19 will be mRNA. However, he further stated that the vaccine cannot be counted alone as it is very difficult to scale. It has a logistic problem. This would require a proper cold chain.
Gates hoped that the mRNA platform would mature in the years ahead to increase vaccines. This will reduce the cost as well as meet the requirement of the cold chain. He also stressed the need for innovation in diagnostics platforms.